IAG Cargo, the cargo division of International Airlines Group (IAG), has further enhanced its global pharmaceuticals offering with the addition of a station at Kuala Lumpur International Airport to its worldwide Constant Climate network.
IAG Cargo
IAG Cargo’s Constant Climate product is a cold chain solution designed specifically for the transportation of pharmaceuticals, such as vaccines, biotech products, and diagnostic samples, along with other temperature-sensitive pharmaceutical materials.
The company’s global network now includes around 100 Constant Climate-approved stations, with the new Kuala Lumpur station served by a daily London Heathrow–Kuala Lumpur service.
The GDP-certified Kuala Lumpur facility is equipped to handle both active and passive temperature-controlled shipments. Customers can also choose IAG Cargo's Critical service, combining the highest priority shipping status with enhanced shipment monitoring for urgent temperature-sensitive shipments.
Jordan Kohlbeck, head of pharmaceutical at IAG Cargo, said: “Adding Kuala Lumpur to our Constant Climate network further enhances IAG Cargo’s presence in Southeast Asia, strengthening both our origin and destination capabilities for pharmaceutical and healthcare shipments. It expands our regional coverage and offers customers greater flexibility when moving temperature-sensitive goods across the globe.
“With around 100 approved Constant Climate stations worldwide, and our state-of-the-art New Premia facility at our London Heathrow headquarters, IAG Cargo is ideally positioned to manage high-value, time- and temperature-sensitive shipments quickly and securely.
“This expansion reflects the growing demand for reliable cold chain solutions, driven by ongoing innovation in life sciences and the increasing need for fast, temperature-controlled transport of biologics, cell and gene therapies, and personalised medicines - all of which rely on the speed and precision that air cargo uniquely provides.”
The addition of Kuala Lumpur comes as IAG Cargo continues to strengthen its pharmaceutical offering through its London Heathrow hub, where it provides third-party handling services for MASkargo. Pharmaceutical shipments routing via Heathrow benefit from dedicated temperature-controlled handling and onward connections across the global Constant Climate network.